Levonadifloxacin
Levonadifloxacin ((S) - (-) -Nadifloxacin; WCK 771) is a broad-spectrum anti-staphylococcal agent. Levonadifloxacin shows antibacterial activity against Methicillin -susceptible Staphylococcus aureus (MSSA) and Methicillin-resistant S. aureus (MRSA) strains, with a reduction of which phagocytized in THP-1 monocytes[1].
Product Specifications
CAS Number
154357-42-3
Product Name Alternative
(S) - (-) -Nadifloxacin; WCK 771
UNSPSC
12352005
Hazard Statement
H301
Target
Antibiotic; Bacterial
Type
Reference compound
Related Pathways
Anti-infection
Applications
COVID-19-immunoregulation
Field of Research
Infection
Assay Protocol
https://www.medchemexpress.com/levonadifloxacin.html
Purity
99.82
Solubility
DMSO : 100 mg/mL (ultrasonic; warming; heat to 60°C) |DMSO : 125 mg/mL (ultrasonic)
Smiles
O=C(C1=CN2[C@@H](C)CCC3=C2C(C1=O)=CC(F)=C3N4CCC(O)CC4)O
Molecular Formula
C19H21FN2O4
Molecular Weight
360.38
Precautions
H301
References & Citations
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
Phase 1
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
![Purified Anti-Human TRAV8-1 Antibody[16G8]](https://cdn.genprice.uk/products/763/68dd14c4061270361e7d70e8/imageurl08/an003680p.webp)
